Pharmaceutical companies face significant drop out rates of their lead candidates due to a lack of efficacy. Our solution directly addresses a critical challenge in drug development journey by de-risking clinical trials through novel, true AI-driven insights derived from the preclinical stage. This is an angle presently not used in AI drug discovery related verticals and represents a gap in the market.
At IntellAif, we are developing an AI-driven solution that enables the in silico assesment of the preclinical data package, optimizing for successful clinical trials at an early stage. Our technology aims to de-risk drug development by enhancing the translational accuracy of preclinical models. The product is a SaaS type platform with our proprietary models accessed, stratified by selected preclinical models. With the incorporation of LLMs and cloud computing power we believe it is a powerful platform to provide the user a research companion to extract insights from preclinical investigations to perform go/no-go analysis on lead candidates.
Company Details
- Employees
- 1
- Founded
- 2025
- Address
- Fogdevreten 6, Stockholm,stockholm County 17165,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.intellaif.com
- Keywords
- Conthey.
- HQ
- Stockholm, Stockholm County
Intellaif Questions
Intellaif's website is http://www.intellaif.com
Intellaif's LinkedIn profile is https://se.linkedin.com/company/intellaif
Intellaif has
1 employees.
View email and phone details for 1
employees at Intellaif.
Intellaif's industry is
Biotechnology Research
Intellaif's top competitors are
Gulf Picasso,
Sigma Software Labs,
Net Zero Build,
Intelligyn,
Olea,
Goodstag,
Grimaldi Development,
Institute For Research In Fundamental Sciences,
Untap!,
Discotek.
Intellaif's categories are Biotechnology Research
Intellaif's founding year is 2025
